Yu et al. posited that PTPN1 may act as an oncogene for promoting breast cancer cellular proliferation [53], with its overexpression can similarly enhance hepatocellular carcinoma cell malignancy and migratory activity [54], whereas PTP1B suppression promotes cell cycle arrest in pancreatic cancer cells in vitro [55]. Here, PTPN1 is linked to breast carcinoma.